This in-person program is for healthcare professionals and offers continuing education (CE) credit.
This activity has been designed to meet the educational needs of nurse involved in the care of patients with hematologic cancers.
At the conclusion of this program, participants will be able to:
- Describe the role of genomics and other testing in diagnostic and treatment approaches for acute myeloid leukemia (AML)
- Identify standard of care and new treatment approaches, including Beat AML® and other clinical trials for AML
- Understand the central role of the nurse in assessment, monitoring for and managing side effects of treatments
- Provide resources for support of the patient and family throughout the treatment process
James M. Foran, MD FRCPC
Associate Professor and Chair, Acute Leukemia & Myeloid Neoplasm Disease Group, Mayo Clinic Cancer Center
Associate Chair of Medicine [Research], Mayo Clinic Florida
Leukemia & Bone Marrow Transplant Programs
Margaret Green, RN, OCN®
Research Nurse Associate
Department of Medicine
Section of Hematology/Oncology
University of Chicago Medicine and Biological Sciences
Darci L. Zblewski, ARNP, C-NP, OCN®
Supervisor, APP Group, Division of Hematology
Continuing Education Information
Registered Nursing Designation
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society National Office under provider number CEP 5832 to award 1.5 continuing education contact hours through the California Board of Registered Nursing.
Disclosure of Conflicts of Interest
The “Conflict of Interest Disclosure Policy” of The Lymphoma & Leukemia Society requires that faculty participating in any CE activity disclose to the audience any relevant relationship(s) with a pharmaceutical, product, or device company. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present.
The Lymphoma & Leukemia Society also requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. The Lymphoma & Leukemia Society has no conflicts of interest with commercial interests related directly or indirectly to this educational activity.
Americans with Disabilities Act
Staff will be glad to assist you with any special needs (physical, dietary, etc.). Please contact us prior to the live program at email@example.com.
Valarie Leishman, RN, BSN
Sponsors and Supporters
This activity is supported by The Leukemia & Lymphoma Society.
Meeting space has been assigned to provide a Symposium supported by The Leukemia & Lymphoma Society during the Oncology Nursing Society’s (ONS) 43rd Annual Congress, May 17 - 20, 2018 in Washington, DC. The Oncology Nursing Society’s assignment of meeting space does not imply product endorsement.